THE Australian Self-Medication Industry has expressed its support for B6/B12 supplements when used according to label directions or the recommendation of a healthcare professional.
ASMI was responding to research based on data from over 77,000 US patients by epidemiologists at Ohio State University Comprehensive Cancer Center, which suggested the intake of high doses of B6 and B12 over a very long period of time was associated with increased lung cancer incidence in male smokers.
The association was not seen in women, and people who had never smoked were excluded from the data analysis, ASMI pointed out.
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Aug 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Aug 17
